Journey Medical Corporation Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION (Tables)

3 Months Ended

Mar. 31, 2026


	Three-Month Periods Ended March 31,
($ in thousands)	2026		2025
Revenue	$	15,961	$	13,139
Less: Segment expenses⁽¹⁾
Cost of goods sold – (excluding amortization of acquired intangible assets)		6,218		4,790
Research and development		—		39
Selling, general and administrative
Employee related		4,688		4,031
Sales, operations, outside services and consulting		2,162		3,078
Marketing related		944		1,057
Stock compensation		989		1,323
Legal and administrative		601		513
Product compliance expense		248		275
Office and administrative		279		226
Other		198		66
Other segment items⁽²⁾		1,864		1,814
Segment expenses		18,191		17,212
Segment loss from operations	$	(2,230)	$	(4,073)

Reconciliation to net loss:
Adjustments and reconciling items		—		—
Net loss	$	(2,230)	$	(4,073)

(1)	The significant expense amounts align with the expenses that the CODM is regularly provided with to assess performance and allocate resources.

(2)	Other segment items for the reportable segment include amortization of intangible assets, interest income (expense), foreign exchange transaction losses and income tax expense.